Results 101 to 110 of about 1,098,707 (256)

Surgical Management of Chronic Pulmonary Embolism [PDF]

, 2017
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life‐threatening complication of acute pulmonary embolism (PE). This entity is the consequence of a persistent obstruction of the pulmonary arteries and progressive vascular remodeling ...
Vallejo, Fabian Andres Giraldo
core   +1 more source

JAK Inhibitors for Treatment of VEXAS Syndrome: A Systematic Review of 186 Cases

Dermatology Research and Practice, Volume 2025, Issue 1, 2025.
Objectives: Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome is an autoinflammatory disease with a wide spectrum of manifestations and no standard treatment. Janus kinase inhibitors (JAK‐I) are small‐molecule drugs that affect many molecular pathways.
Saeed Bahramian, Patrick Fazeli, Arezou Rafati, Sardar Demokri, Huria Memari, Amirali Soheili, Farzad Esmaeili, Mohammad Pourmehdi Ardebili, Haniye Erfani, Seyed Mohammad Vahabi, Ioannis D. Bassukas   +10 more
wiley   +1 more source

Surgical intervention for left main compression syndrome due to severe secondary pulmonary hypertension

Cardiology Plus, 2017
A 51-year-old man presented with non-ST-elevation myocardial infarction due to extrinsic compression of the left main coronary artery (LMCA) caused by a dilated pulmonary artery (PA) with secondary pulmonary hypertension and was successfully treated with
Laichun Song, Ming Xu, Chao Tao, Lei Shi, Bo Wang, Huadong Yu, Xufa Chen, Liang Tao, Xi Su   +8 more
doaj   +1 more source

Birth of the Modern Era of CTEPH Diagnosis and Care

Pulmonary Circulation, Volume 15, Issue 4, October 2025.
William R. Auger
wiley   +1 more source

Same‐Day Discharge Following Outpatient Balloon Pulmonary Angioplasty: A Single‐Center Experience

Pulmonary Circulation, Volume 14, Issue 4, October 2024.
ABSTRACT Overnight inpatient monitoring is common following balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). We describe our institutional experience in same‐day discharge (SDD) after BPA. Across 78 BPA sessions, there were only 2 (2.6%) admissions for hemoptysis with no reperfusion lung injury or deaths at
Amit Saha, Jeffrey P. Chidester, Hurst M. Hall, Trushil Shah, Kelly M. Chin, Sonja D. Bartolome, Thomas P. Koshy   +6 more
wiley   +1 more source

Chronic Thromboembolic Pulmonary Hypertension [PDF]

, 2010
The pulmonary hypertension (PH) and right heart dysfunction that results from chronic thromboembolic involvement of the pulmonary vascular bed is potentially curable with surgical endarterectomy. Over the past several decades, growing clinical experience
A Keogh, A Ribeiro, AG Corsico, B Thompson, CJ Archibald, E Mayer, F Reichenberger, FG Vassallo, J Suntharalingam, K Jensen, K Moser, Lara M. Wittine, M Miniati, M Wolf, MM Hoeper, N Kim, N Nagaya, N Skoro-Sajer, P Bresser, P Darteville, PA Thistlethwaite, PA Thistlethwaite, PA Thistlethwaite, R Condliffe, R Hartz, RJ Hughes, S Cabrol, S Jamieson, S Krug, T Iwase, T Kramm, V Pengo, William R. Auger, WR Auger, X Jais   +34 more
core   +3 more sources

Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?

Pulmonary Circulation, 2023
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by persistent organized thromboembolic obstruction of the pulmonary arteries from incompletely resolved pulmonary embolism.
Jenny Z. Yang, David S. Poch, Lawrence Ang, Ehtisham Mahmud, Nick H. Kim   +4 more
doaj   +1 more source

Computed tomography identifies sex-specific differences in surgical chronic thromboembolic pulmonary hypertension

JHLT Open
Background: Registry data suggest women are less likely than men to undergo pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension despite a similar proportion of proximal vs distal disease.
Marie Bambrick, MBBChBAO, FFRRCSI, Grace Grafham, MSc, Katherine Lajkosz, MSc, Laura Donahoe, MD, MSc, FRCSC, Marc de Perrot, MD, MSc, FRCSC, Micheal McInnis, MD, FRCPC   +5 more
doaj   +1 more source

Biochemical markers in the management of pulmonary hypertension. [PDF]

, 2005
Pulmonary arterial hypertension (PAH) is a severe disease usually diagnosed by echocardiography and further confirmed by right heart catheterisation. Follow-up under treatment consists in assessment of clinical signs, various types of exercise testing ...
Aubert, J.D.
core  

Reorganized subtotal perfusion blockade of a pulmonary artery without hypertension after successfully lysed massive PE – A case report

Pulmonary Circulation, Volume 14, Issue 3, July 2024.
Abstract We present the case of an 18‐year‐old woman with a 5‐day history of thoracic pain and dyspnea following physical exertion, along with swelling of her right calf. Computertomography (CT) angiography confirmed a massive central pulmonary artery embolism (PE) of the left main branch. The patient underwent catheter‐directed thrombolysis.
Hendrik Scheidhauer, Sven Moebius‐Winkler, Franz Haertel, Daniel Kretzschmar   +3 more
wiley   +1 more source